Cargando…
Exploring the Trypanosoma brucei Hsp83 Potential as a Target for Structure Guided Drug Design
Human African trypanosomiasis is a neglected parasitic disease that is fatal if untreated. The current drugs available to eliminate the causative agent Trypanosoma brucei have multiple liabilities, including toxicity, increasing problems due to treatment failure and limited efficacy. There are two a...
Autores principales: | Pizarro, Juan Carlos, Hills, Tanya, Senisterra, Guillermo, Wernimont, Amy K., Mackenzie, Claire, Norcross, Neil R., Ferguson, Michael A. J., Wyatt, Paul G., Gilbert, Ian H., Hui, Raymond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798429/ https://www.ncbi.nlm.nih.gov/pubmed/24147171 http://dx.doi.org/10.1371/journal.pntd.0002492 |
Ejemplares similares
-
Identification, subcellular localization, biochemical properties, and high-resolution crystal structure of Trypanosoma brucei UDP-glucose pyrophosphorylase
por: Mariño, Karina, et al.
Publicado: (2010) -
Phosphoglucomutase is absent in Trypanosoma brucei and redundantly substituted by phosphomannomutase and phospho-N-acetylglucosamine mutase
por: Bandini, Giulia, et al.
Publicado: (2012) -
Discovery of Inhibitors of Trypanosoma brucei by Phenotypic Screening of a Focused Protein Kinase Library
por: Woodland, Andrew, et al.
Publicado: (2015) -
In silico analysis of the HSP90 chaperone system from the African trypanosome, Trypanosoma brucei
por: Jamabo, Miebaka, et al.
Publicado: (2022) -
SUMOylation in Trypanosoma brucei
por: Klein, Cornelia Andrea, et al.
Publicado: (2013)